Published in Dtsch Med Wochenschr on November 04, 1988
Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70
Receptor sites for complement on certain human peripheral blood lymphocytes. J Immunol (1970) 4.09
Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07
Ascent of dinosaurs linked to an iridium anomaly at the Triassic-Jurassic boundary. Science (2002) 3.69
Serum levels of cytokines in chronic liver diseases. Gastroenterology (1992) 3.47
Crystal structure of the thermosome, the archaeal chaperonin and homolog of CCT. Cell (1998) 2.94
Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J Biol Chem (1988) 2.74
Taxonomic relations between archaebacteria including 6 novel genera examined by cross hybridization of DNAs and 16S rRNAs. J Mol Evol (1982) 2.64
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16
Incorporation of six additional proteins to complete the assembly map of the 50 S subunit from Escherichia coli ribosomes. J Biol Chem (1987) 2.15
Intraoperative cryoanalgesia for postthoracotomy pain relief. Ann Thorac Surg (1989) 2.11
Ferroglobus placidus gen. nov., sp. nov., A novel hyperthermophilic archaeum that oxidizes Fe2+ at neutral pH under anoxic conditions. Arch Microbiol (1996) 2.06
Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood (1992) 2.05
Operation for N2 small cell lung carcinoma. Ann Thorac Surg (1990) 2.04
A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol (1999) 2.03
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90
Presence of acetyl coenzyme A (CoA) carboxylase and propionyl-CoA carboxylase in autotrophic Crenarchaeota and indication for operation of a 3-hydroxypropionate cycle in autotrophic carbon fixation. J Bacteriol (1999) 1.86
The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol (1970) 1.82
Correct folding of circularly permuted variants of a beta alpha barrel enzyme in vivo. Science (1989) 1.76
In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol (1969) 1.73
Heterologous expression of Arabidopsis phytochrome B in transgenic potato influences photosynthetic performance and tuber development. Plant Physiol (1999) 1.72
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br J Cancer (2003) 1.71
Respiration of arsenate and selenate by hyperthermophilic archaea. Syst Appl Microbiol (2000) 1.70
The importance of surgical and multimodality treatment for small cell bronchial carcinoma. J Thorac Cardiovasc Surg (1989) 1.65
Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases. Eur J Gastroenterol Hepatol (1995) 1.64
Reclassification of the crenarchael orders and families in accordance with 16S rRNA sequence data. Int J Syst Bacteriol (1997) 1.63
A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene (2006) 1.62
Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child (1991) 1.61
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J Clin Oncol (1998) 1.61
Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet (1995) 1.59
Inhibition of capillary migration by antigen-antibody complexes. J Immunol (1969) 1.55
IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55
Heterotopic ossification in pedicled intercostal muscle flaps causing clinical problems. J Thorac Cardiovasc Surg (1998) 1.53
Organic solutes in hyperthermophilic archaea. Appl Environ Microbiol (1997) 1.49
PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene (2006) 1.48
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene (2009) 1.43
Towards the ecology of hyperthermophiles: biotopes, new isolation strategies and novel metabolic properties. FEMS Microbiol Rev (2000) 1.42
Nitric oxide induces apoptosis in mouse thymocytes. J Immunol (1995) 1.40
Detection of flexor tenosynovitis by magnetic resonance imaging: its relationship to diurnal variation of symptoms. J Rheumatol (1991) 1.40
Protracted infection of pacemaker leads with development of large vegetations: three years follow up. Case report. Vnitr Lek (2003) 1.39
Effects of Taxol on choriocarcinoma cells. Am J Obstet Gynecol (1995) 1.39
Atrial natriuretic peptide (ANP), aldosterone, angiotensin II and renin in the 'low T3 syndrome' in organ donors. Infusionsther Transfusionsmed (1992) 1.39
Axillocoronary bypass for severely atherosclerotic aorta in coronary artery bypass grafting. J Thorac Cardiovasc Surg (1998) 1.39
Thiobacillus ferrooxidans, a facultative hydrogen oxidizer. Appl Environ Microbiol (1990) 1.30
The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol (2012) 1.29
Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J Immunol (2001) 1.24
Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. Br J Haematol (1970) 1.23
The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J Biol Chem (1997) 1.21
ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene (2008) 1.21
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol (1999) 1.20
In vivo observation of cell division of anaerobic hyperthermophiles by using a high-intensity dark-field microscope. J Bacteriol (1999) 1.20
The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol (2002) 1.20
Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer (1997) 1.19
Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation (1990) 1.18
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial. Br J Cancer (2000) 1.17
Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest (2000) 1.15
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) (2008) 1.13
Classification of complications after progressive long bone lengthening: proposal for a new classification. Orthop Traumatol Surg Res (2012) 1.12
Electron microscopic studies of human monocyte and lymphocyte interaction with immunoglobulin- and complement-coated erythrocytes. Exp Cell Res (1972) 1.11
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood (1996) 1.11
IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr (1989) 1.11
Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med (2000) 1.11
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol (2008) 1.09
Nuclear magnetic resonance spectroscopy. Carbon-13 spin-lattice relaxation time measurements of amino acids. Proc Natl Acad Sci U S A (1974) 1.07
Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol Genomics (2010) 1.07
Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J (1996) 1.07
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer (1995) 1.06
Nucleoid structure and partition in Methanococcus jannaschii: an archaeon with multiple copies of the chromosome. Genetics (1999) 1.06
IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol (1988) 1.06
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine (1995) 1.05
The Zurich Study: participation patterns and Symptom Checklist 90-R scores in six interviews, 1979-99. Acta Psychiatr Scand Suppl (2003) 1.05
Neopterin in clinical practice. Clin Chim Acta (1991) 1.04
Chronomics, neuroendocrine feedsidewards and the recording and consulting of nowcasts--forecasts of geomagnetics. Biomed Pharmacother (2005) 1.03
Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res (1997) 1.03
Prodromal features for Parkinson's disease--baseline data from the TREND study. Eur J Neurol (2014) 1.03
Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med (1998) 1.02
Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters. Ann Hematol (1991) 1.02
An SH3 domain is required for the mitogenic activity of microinjected phospholipase C-gamma 1. FEBS Lett (1995) 1.02
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group. Ann Oncol (2004) 1.01
Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res (2000) 1.00
In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin Exp Immunol (1988) 0.99
The effect of anti-lymphocyte globulin on human monocytes in vitro. Clin Exp Immunol (1969) 0.98
Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand J Immunol (1997) 0.98
Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol (2001) 0.98
Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation (1990) 0.98
Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol (1991) 0.98
Purification and properties of an extremely thermostable membrane-bound sulfur-reducing complex from the hyperthermophilic Pyrodictium abyssi. Eur J Biochem (1998) 0.97
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet (2000) 0.97
Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(Ipr) mice. J Autoimmun (2000) 0.96
Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells. Cancer Res (1990) 0.96
[Properties and subcellular localization of newly synthesized proteins of human lymphocytes in vitro with and without the addition of phytohemagglutinin]. Klin Wochenschr (1967) 0.96
Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation. Int J Cancer (1995) 0.96